ITGB1 and prostate cancer: These results lead to the proposal that cell adhesion is a major prostate cancer hallmark modulated by miR-183, and ITGB1 is a target of miR-183 repression in PrCa, contributing to this phenotype in vitro and possibly in the clinical set.